Michael Becka
Impact in
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Venous Thromboembolism Diagnosis and Management 20
- Hematology 19
- Blood Coagulation and Thrombosis Mechanisms 19
- Co-authors
- Dagmar Kubitza (28 shared papers)Wolfgang Mueck (19 shared papers)Michael Zuehlsdorf (12 shared papers)Barbara Voith (5 shared papers)Georg Wensing (4 shared papers)Jan Julius Stampfuss (2 shared papers)Angelika Roth (3 shared papers)Michael Voelker (3 shared papers)
- Journals
- British Journal of Clinical Pharmacology (6 papers)The Journal of Clinical Pharmacology (6 papers)Blood (5 papers)Atherosclerosis (2 papers)Archives of Toxicology (2 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Michael Becka
49 papers receiving 5.3k citations
Michael Becka's Hit Papers
Peers
Comparison fields: 5 of 100
- Internal Medicine 1.8k
- Cardiology and Cardiovascular Medicine 2.2k
- Hematology 810
- Pharmacology 549
- Hepatology 259
Countries citing papers authored by Michael Becka
This map shows the geographic impact of Michael Becka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Becka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Becka more than expected).
Fields of papers citing papers by Michael Becka
This network shows the impact of papers produced by Michael Becka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Becka. The network helps show where Michael Becka may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Becka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Serum markers detect the presence of liver fibrosis: A cohort study Hit paper breakdown → | 2004 | 935 |
| 2 | 2005 | 539 | |
| 3 | 2005 | 534 | |
| 4 | Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban Hit paper breakdown → | 2013 | 479 |
| 5 | 2010 | 364 | |
| 6 | Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects Hit paper breakdown → | 2013 | 330 |
| 7 | 2007 | 296 | |
| 8 | 2008 | 222 | |
| 9 | 2006 | 215 | |
| 10 | 2013 | 184 | |
| 11 | 2013 | 178 | |
| 12 | 2006 | 153 | |
| 13 | 2007 | 145 | |
| 14 | 2006 | 133 | |
| 15 | 2007 | 126 | |
| 16 | 2013 | 98 | |
| 17 | 2006 | 70 | |
| 18 | 2005 | 64 | |
| 19 | 2019 | 63 | |
| 20 | 2001 | 56 |
About Michael Becka
Michael Becka is a scholar working on Internal Medicine, Hematology, Pharmacology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health, having authored 51 papers that have together received 5.7k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (20 papers), Blood Coagulation and Thrombosis Mechanisms (19 papers), Pharmacogenetics and Drug Metabolism (14 papers), Atrial Fibrillation Management and Outcomes (9 papers), Pharmaceutical studies and practices (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Cardiac Fibrosis and Remodeling (3 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). The work is most often cited by research in Internal Medicine (1.8k citations), Cardiology and Cardiovascular Medicine (2.2k citations), Hematology (810 citations), Pharmacology (549 citations) and Hepatology (259 citations). Michael Becka has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Dagmar Kubitza, Wolfgang Mueck, Michael Zuehlsdorf, Barbara Voith, Georg Wensing, Jan Julius Stampfuss, Angelika Roth, Michael Voelker, William Rosenberg and Alastair D. Burt. Their work appears in journals such as British Journal of Clinical Pharmacology, The Journal of Clinical Pharmacology, Blood, Atherosclerosis and Archives of Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.